Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+5.51%
Variazione Mensile
-9.20%
Variazione di 6 mesi
-42.34%
Variazione Annuale
-13.27%
Chiusura Precedente
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volume
143
Mercati
Mercato Azionario Statunitense
Salute
SLNO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Notizie
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
Il titolo Soleno Therapeutics tocca il minimo di 52 settimane a 39,42 USD
Soleno Therapeutics stock hits 52-week low at 39.42 USD
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright